Dr. Maria Babak serves as an assistant professor at the City University of Hong Kong and leads the Drug Discovery Lab there. She ranks among the top 2% of the most cited researchers globally, as per the Stanford/Elsevier ranking. In 2022, she received the prestigious Graeme Hanson-AsBIC Early Career Award, recognizing her contributions as an early career researcher in the Asia Pacific region, particularly in the realm of biological inorganic chemistry. Further, in 2024, Dr. Babak received the Yvonne Award, celebrating emerging leaders in cancer care. Her research spans the interdisciplinary domains of chemistry, biology, and medicine, with a primary focus on discovering and advancing preclinical development of anticancer therapies for resistant and aggressive cancers lacking effective treatment options. Additionally, she directs efforts towards innovating detection methods for counterfeit anticancer medications. Dr. Babak actively contributes as a board member of the Institute of Cancer and Crisis, dedicated to alleviating the challenges faced by cancer patients during crises.
Updated: October 2024